{"id":97048,"date":"2024-01-10T05:14:42","date_gmt":"2024-01-10T05:14:42","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=115571"},"modified":"2024-01-10T05:14:42","modified_gmt":"2024-01-10T05:14:42","slug":"nyxoah-announces-preliminary-results-for-the-fourth-quarter-and-full-year-2023","status":"publish","type":"post","link":"https:\/\/jordannewsgazette.com\/nyxoah-announces-preliminary-results-for-the-fourth-quarter-and-full-year-2023\/","title":{"rendered":"Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023"},"content":{"rendered":"
\n

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023<\/strong><\/p>\n

Mont-Saint-Guibert, Belgium \u2013 January 9, 2024, 10:05pm CET \/ 4:05pm ET \u2013 Nyxoah SA (Euronext Brussels\/Nasdaq: NYXH)<\/strong> (\u201cNyxoah\u201d or the \u201cCompany\u201d), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced certain preliminary, unaudited results for the fourth quarter and full year ended December 31, 2023.<\/p>\n

Preliminary, Unaudited Fourth Quarter and Full Year 2023 Results<\/strong><\/p>\n